Geode Capital Management’s Orchestra BioMed OBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $810K | Sell |
302,082
-293,350
| -49% | -$786K | ﹤0.01% | 3398 |
|
|
2025
Q1 | $2.55M | Buy |
595,432
+22,991
| +4% | +$98.4K | ﹤0.01% | 2948 |
|
|
2024
Q4 | $2.29M | Buy |
572,441
+5,222
| +0.9% | +$20.9K | ﹤0.01% | 3083 |
|
|
2024
Q3 | $2.92M | Buy |
567,219
+11,002
| +2% | +$56.6K | ﹤0.01% | 3009 |
|
|
2024
Q2 | $4.53M | Buy |
556,217
+116,119
| +26% | +$947K | ﹤0.01% | 2786 |
|
|
2024
Q1 | $2.32M | Buy |
440,098
+14,349
| +3% | +$75.6K | ﹤0.01% | 3058 |
|
|
2023
Q4 | $3.89M | Buy |
425,749
+10,044
| +2% | +$91.7K | ﹤0.01% | 2829 |
|
|
2023
Q3 | $3.63M | Buy |
415,705
+220,949
| +113% | +$1.93M | ﹤0.01% | 2798 |
|
|
2023
Q2 | $1.36M | Buy |
194,756
+69,750
| +56% | +$488K | ﹤0.01% | 3239 |
|
|
2023
Q1 | $2.45M | Buy |
125,006
+112,585
| +906% | +$2.2M | ﹤0.01% | 2945 |
|
|
2022
Q4 | $124K | Hold |
12,421
| – | – | ﹤0.01% | 4311 |
|
|
2022
Q3 | $123K | Hold |
12,421
| – | – | ﹤0.01% | 4469 |
|
|
2022
Q2 | $123K | Hold |
12,421
| – | – | ﹤0.01% | 4502 |
|
|
2022
Q1 | $123K | Hold |
12,421
| – | – | ﹤0.01% | 4583 |
|
|
2021
Q4 | $124K | Buy |
12,421
+2,033
| +20% | +$20.3K | ﹤0.01% | 4654 |
|
|
2021
Q3 | $102K | Hold |
10,388
| – | – | ﹤0.01% | 4669 |
|
|
2021
Q2 | $105K | Buy |
+10,388
| New | +$105K | ﹤0.01% | 4546 |
|